REGULATION AND FUNCTION OF SPARC IN MALE REPRODUCTION
Project Number5R01HD025059-02
Contact PI/Project LeaderVERNON, ROBERT B
Awardee OrganizationUNIVERSITY OF WASHINGTON
Description
Abstract Text
Spermatogenesis in the mammalian testis is regulated in part by a complex
set of interactions among the nongerminal Sertoli, Leydig, and
peritubular cells that create a unique environment for the maturation of
spermatozoa. A calcium-binding protein, SPARC (Secreted Protein, Acidic
and Rich in Cysteine) has been identified in the cytoplasm of a
population of murine Sertoli cells bearing Late-stage spermatids. Both
SPARC mRNA and protein have been localized to murine interstitial Leydig
cells. In addition, several monoclonal antibodies that reacted with mouse
sperm surface antigens and inhibited in vitro fertilization were shown to
cross-react with SPARC. SPARC, initially described as a differentiation-
associated product of murine extraembryonic endoderm and teratocarcinoma
cells, has been molecularly cloned. The complete cDNA sequence revealed a
cysteine-rich "finger" sequence partially homologous to the protease
inhibitor ovomucoid, and a Ca+2 binding "EF Hand" similar to those
present in calmodulin and parvalbumin.
Our observations suggest SPARC plays a role in male reproduction, and we
propose to study, in the murine testis, the function and regulation of
this well-characterized molecule. Accordingly, the distribution of SPARC
mRNA and protein in embryonic, prepubertal and adult testes, and mature
sperm will be determined by immunocytochemistry and in situ nucleic acid
hybridization at light and electron microscopic levels. Binding, uptake
and processing of radiolabeled SPARC by testis tissue will be monitored
in vivo, and putative SPARC-binding receptors will be isolated from
testis tissue and fluids. We will determine if SPARC can bind to cultured
Leydig and Sertoli cells to induce changes in cell shape and protein
biosynthesis. We will study hormonal regulation of the Sparc gene in
Leydig cell cultures exposed to hCG, and interaction of transcription
factors with domains of the SPARC promoter. In cultured Leydig cells, the
ability of exogeneous SPARC to alter steroid production in response to
hCG will be examined. Finally, we will study the fate of sperm-associated
SPARC during capacitation in vitro and effects of added SPARC and anti-
SPARC antibodies on mouse in vitro fertilization.
These experiments focus on a well-characterized molecule whose function
and genetic regulation will be examined during testicular development and
spermatogenesis.
Eunice Kennedy Shriver National Institute of Child Health and Human Development
CFDA Code
DUNS Number
605799469
UEI
HD1WMN6945W6
Project Start Date
01-September-1989
Project End Date
31-August-1992
Budget Start Date
01-September-1990
Budget End Date
31-August-1991
Project Funding Information for 1990
Total Funding
$126,684
Direct Costs
$82,800
Indirect Costs
$43,884
Year
Funding IC
FY Total Cost by IC
1990
Eunice Kennedy Shriver National Institute of Child Health and Human Development
$126,684
Year
Funding IC
FY Total Cost by IC
Sub Projects
No Sub Projects information available for 5R01HD025059-02
Publications
Publications are associated with projects, but cannot be identified with any particular year of the project or fiscal year of funding. This is due to the continuous and cumulative nature of knowledge generation across the life of a project and the sometimes long and variable publishing timeline. Similarly, for multi-component projects, publications are associated with the parent core project and not with individual sub-projects.
No Publications available for 5R01HD025059-02
Patents
No Patents information available for 5R01HD025059-02
Outcomes
The Project Outcomes shown here are displayed verbatim as submitted by the Principal Investigator (PI) for this award. Any opinions, findings, and conclusions or recommendations expressed are those of the PI and do not necessarily reflect the views of the National Institutes of Health. NIH has not endorsed the content below.
No Outcomes available for 5R01HD025059-02
Clinical Studies
No Clinical Studies information available for 5R01HD025059-02
News and More
Related News Releases
No news release information available for 5R01HD025059-02
History
No Historical information available for 5R01HD025059-02
Similar Projects
No Similar Projects information available for 5R01HD025059-02